Clinical Trials Directory

Trials / Completed

CompletedNCT00997594

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Mie University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate changes in adrenal hormones during adrenal radiofrequency (RF) ablation.

Detailed description

Adrenal radiofrequency (RF) ablation has been increasingly used for the treatment of unresectable adrenal tumors. But one of the major complication is a increase in blood pressure. Hormonal release during RF ablation is considered the cause of hypertension. But there has been no evidence that adrenal hormones affects changes in blood pressure. In this prospective study, we evaluate the changes in adrenal hormones during RF ablation and clarify the cause of hypertensive crisis.

Conditions

Interventions

TypeNameDescription
PROCEDURERadiofrequency ablationRadiofrequency (RF) ablation was done after RF electrodes were placed in the adrenal tumor in the adrenal RF ablation group. RF ablation was done after RF electrodes were placed in the targeted abdominal tumors other than adrenal gland in the abdominal RF ablation other than adrenal gland group.

Timeline

Start date
2009-10-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2009-10-19
Last updated
2015-04-28
Results posted
2011-02-23

Locations

2 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT00997594. Inclusion in this directory is not an endorsement.

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation (NCT00997594) · Clinical Trials Directory